Siga Technologies (SIGA) EBITDA Margin Growth (1y) (2011 - 2025)

Siga Technologies (SIGA) EBITDA Margin Growth (1y) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 304.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -157.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,330.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -650.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,630.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1,962.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 111.00
10 Siga Technologies 225.56 Mn 70.59 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -39,559.00
Jun 30, 2025 5,136.00
Mar 31, 2025 -7,637.00
Dec 31, 2024 -863.00
Sep 30, 2024 1,959.00
Jun 30, 2024 8,386.00
Mar 31, 2024 6,967.00
Dec 31, 2023 9,459.00
Sep 30, 2023 -7,355.00
Jun 30, 2023 -9,733.00
Mar 31, 2023 -1,168.00
Dec 31, 2022 -9,740.00
Sep 30, 2022 12,012.00
Jun 30, 2022 1,841.00
Mar 31, 2022 2,768.00
Dec 31, 2021 1,047.00
Sep 30, 2021 -13,507.00
Jun 30, 2021 -7,136.00
Mar 31, 2021 11,128.00
Dec 31, 2020 15,242.00